Organometallics
Article
1
0H, Cp), 3.85 (t, J = 2.6 Hz, 2H, H1 + H4), 2.38 2.32 (m, 2H,
126.9 (CH), 125.6 (CH), 112.0 (CH), 111.6 (CH), 93.0 (CH), 83.4
CH (Ad)), 2.32 2.26 (m, 3H, CH + CH(Ad)), 2.21 2.14 (m, 3H, CH
(CH), 63.0 (C), 62.0 (CH), 21.0 (CH ), 20.9 (CH ). LR-MS (EI, m/z,
2
2
2
3
3
13
+
+
+
CH(Ad)), 2.08 2.03 (m, 2H, CH (Ad)), 1.82 (m, 2H, 2CH(Ad)). C
relative intensity (%)): 690 ([M ], 7), 584 ([M − C H CHO], 4), 478
2
6
5
+
+
NMR (151 MHz, C D ): δ 117.7 (C), 108.2 (CH), 106.7 (CH), 106.5
([M − 2{C H CHO}], 19), 413 ([M − 2{C H CHO} − Cp], 7), 326
6
6
6
5
6
5
+
+
+
(
2
5
C), 106.2 (CH), 44.3 (CH ), 39.0 (CH ), 38.8 (CH ), 36.9 (CH),
([M − {C H CHO} − Fv], 100), 258 ([Fv ], 39), 220 ([Cp Zr ], 98),
2
2
2
6
5
2
+
+
9.6(CH), 29.1 (CH). LR-MS (EI, m/z, relative intensity): 418 ([M ],
91 ([C H -CH ], 91).
6 4 3
+
+
+
), 353 ([M − Cp], 3), 220 ([M − Fv], 15), 198 ([M − Cp Zr], 100).
Cp Zr[OCH(p-Br-Ph)C(p-tolyl) C H CH(p-Br-Ph)O] (3b; NMR
2
2
2
5
3
No correct elemental analysis of the bulk product was obtained, despite
several attempts.
Experiment). To a C D solution of complex 2c (20 mg, 0.04
6 6
mmol) was added p-bromobenzaldehyde (15 mg, 0.08 mmol) and after
1
Cp Zr(6,6-di-p-tolylfulvene) (2c). According to GP-1, 6,6-di-p-
stirring for 30 min H NMR confirmed full conversion to complex 3a.
2
1
tolylfulvene (258 mg, 1.0 mmol) was reacted for 4 h to give complex 2c
H NMR (500 MHz, C D ): δ 7.81 (d, J = 8.3 Hz, 2H, m-CH, Ar), 7.46
6 6
1
as an orange-yellow powder in 50% yield (240 mg, 0.5 mmol). H NMR
(d, J = 8.4 Hz, 2H, m-CH, Ar), 7.28 (d, J = 8.5 Hz, 2H, m-CH, p-tol), 7.20
(d, J = 8.3 Hz, 2H, m-CH, p-tol), 7.17 (d, J = 8.2 Hz, 2H, o-CH, Ar), 7.06
(d, J = 8.5, 3.0 Hz, 2H, o-CH, Ar), 7.06 (d, J = 8.5, 3.0 Hz, 2H, o-CH, p-
tol), 6.92 (d, J = 8.1 Hz, 2H, o-CH, p-tol), 6.83 (d, J = 5.3 Hz, 1H, H4),
6.22−6.17 (m, 1H, H3), 6.09 (s, 5H, Cp), 5.96 (s, 6H, Cp + H1), 5.40 (s,
1H, H21), 5.22 (s, 1H, H28), 3.42 (s, 1H, H ), 2.28 (s, 3H, CH ), 2.16
(
4
500 MHz, C D ): δ 7.79 (d, J = 8.2 Hz, 4H, o-CH), 7.03 (d, J = 7.9 Hz,
6 6
H, m-CH), 5.49 (t, J = 2.6 Hz, 2H, H2 + H3), 5.13 (s, 10H, Cp), 4.50 (t,
13
J = 2.6 Hz, 2H, H1 + H4), 2.17 (s, 6H, CH3). C NMR (126 MHz,
C D ): δ 146.3 (C), 134.1 (C), 129.8 (CH), 128.7 (CH), 117.5 (C),
6
6
1
09.8 (CH), 109.1 (CH), 108.8 (CH), 103.8 (C), 21.0 (CH ). LR-MS
3
2
3
+
+
13
(
EI, m/z, relative intensity (%)): 478 ([M ], 26), 258 ([M − Cp Zr],
00), 220 ([M − Fv], 76). No correct elemental analysis of the bulk
(s, 3H, CH ). C NMR (125 MHz, C D ) δ152.7 (C), 146.5 (C), 143.7
2
3
6
6
+
1
(C), 142.3 (C), 140.4 (C), 136.5 (CH), 136.2 (C), 136.1 (CH), 135.9
(C), 133.5 (CH), 132.0 (CH), 131.9 (CH), 131.7 (CH), 131.6 (CH),
131.0 (CH), 128.3 (CH), 127.8 (CH), 127.3 (CH), 121.3 (C), 120.6
(C), 112.0 (CH), 111.6 (CH), 92.1 (CH), 82.6 (CH), 62.7 (C), 61.6
product was obtained, despite several attempts. Crystals of complex 2c
suitable for X-ray studies were grown from a concentrated C D6
6
solution.
+
Cp Zr(6,6-diphenylfulvene) (2d). According to GP-2, Cp ZrCl
(CH), 21.0 (CH ), 20.9 (CH ). ESI-MS for [C H O Br ZrK] : calcd
2
2
2
3
3
44 38
2
2
(
(
2.34 g, 8.0 mmol), Mg (0.19 g, 8.0 mmol), and 6,6-diphenylfulvene
884.9923, found 884.9913. Crystals suitable for X-ray studies were
1.84 g, 8.0 mmol) were reacted to give complex 2d as an orange-yellow
grown from a concentrated C D solution.
6
6
1
powder in 65% yield (2.35 g, 5.2 mmol). H NMR (500 MHz, C D ): δ
7
Cp Zr[OCH(p-MeO-Ph)C(p-tolyl) C H CH(p-MeO-Ph)O] (3c;
6
6
2
2
5
3
3
.83 (m, 4H, phenyl), 6.94−7.20 (m, 6H, phenyl), 5.45 (t, J = 2.6 Hz,
H, H2 + H3), 5.08 (s, 10H, Cp), 4.44 (t, J = 2.6 Hz, 2H, H1 + H4).
NMR Experiment). To a C D solution of complex 2c (20 mg, 0.04
6 6
HH
3
2
mmol) was added p-anisaldehyde (11 mg, 0.08 mmol), and after stirring
HH
1
3
1
1
C NMR (126 MHz, C D ): δ 148.9 (C), 129.8 (CH), 128.5 (CH),
for 30 min H NMR confirmed full conversion to complex 3c. H NMR
6
6
(
500 MHz, C D ): δ 7.89 (d, J = 8.3 Hz, 2H, o-CH, p-tol), 7.30 (d, J = 8.3
1
(
25.0 (CH), 117.2 (C), 109.8 (CH), 109.1 (CH), 108.9 (CH), 103.9
6
6
+
+
Hz, 2H, o-CH, p-tol), 7.29 (d, J = 8.6 Hz, 2H, o-CH, anisyl) 7.26 (d, J =
.7 Hz, 2H, o-CH, anisyl), 7.17 (d, J = 8.3 Hz, 2H, m-CH, p-tol), 6.94 (d,
C). LR-MS (EI, m/z, relative intensity (%)): 450 ([M ], 16), 385 ([M
+
+
8
−
Cp], 7), 230 ([M − Cp Zr], 100), 220 (([M − Fv], 69). No correct
2
J = 8.6 Hz, 2H, m-CH, anisyl), 6.92 (d, J = 8.2 Hz, 2H, m-CH, p-tol), 6.84
(d, J = 5.1 Hz, 1H, H4), 6.74 (d, J = 8.7 Hz, 2H, m-CH, anisyl), 6.35 (d, J
elemental analysis of the bulk product was obtained, despite several
attempts. Crystals of complex 2d suitable for X-ray studies were grown
from a toluene solution at −15 °C. The compound crystallizes with 0.5
equiv of toluene.
=
5.4 Hz, 1H, H3), 6.11 (s, 5H, Cp), 6.03 (s, 6H, Cp + H1), 5.52 (s, 1H,
H21), 5.40 (s, 1H, H28), 3.55 (s, 1H, H2), 3.43 (s, 3H, OMe), 3.28 (s,
13
Cp Zr(6,6-di-p-fluorophenylfulvene) (2e). According to GP-2,
3H, OMe), 2.23 (s, 3H, CH
), 2.10 (s, 3H, CH ). C NMR (125 MHz,
3 3
2
Cp ZrCl (2.00 g, 6.84 mmol), Mg (0.17 g, 6.84 mmol), and 6,6-di-p-
C D
6 6
): δ 159.1 (C), 159.0 (C), 153.0 (C), 142.9 (C), 141.0 (C), 139.8
2
2
fluorophenylfulvene (1.82 g, 6.84 mmol) were reacted to give complex
(C), 136.9 (C), 136.4 (CH), 136.2 (CH), 135.9 (C), 135.6 (C), 133.9
(CH), 132.2 (CH), 131.9 (CH), 131.3 (CH), 128.3 (CH), 127.7 (CH),
126.7 (CH), 114.0 (CH), 113.5 (CH), 112.0 (CH), 111.5 (CH), 92.4
1
2
e as an orange-yellow powder in 72% yield (2.41 g, 4.92 mmol). H
3
4
NMR (500 MHz, C D ): δ 7.50 (m, J = 8.5 Hz, J = 5.6 Hz, 4H, o-
CH), 6.83 (m, J = 8.5 Hz, J = 9.0 Hz, 4H, m-CH), 5.44 (t, J =
6
6
HH
HF
3
3
3
(CH), 83.1 (CH), 62.9 (C), 62.3 (CH), 54.9 (CH
), 54.7 (CH
), 21.1
H O ZrNa] : calcd 773.2184,
44 4
HH
HF
HH
3
3
3
+
2
.6 Hz, 2H, H2 + H3), 5.03 (s, 10H, Cp), 4.26 (t, J = 2.6 Hz, 2H, H1
(CH
found 773.2195.
Cp Zr[OCMe
3
), 20.9 (CH
3
). ESI-MS for [C46
C(p-tolyl) CMe O] (3d). According to GP-3,
2
HH
1
+
(
H4). 13C NMR (126 MHz, C D ): δ 160.8 ( J = 244 Hz, C), 144.9
6 6 CF
4J = 3.0 Hz, C), 129.8 ( J = 7.0 Hz, CH), 117.2 (C), 114.7 ( J
3
2
=
F
C
2
H
5
CF
CF
CF
2
2
3
19
2
1.0 Hz, CH), 109.7 (CH), 109.1 (CH), 109.0 (CH), 101.1 (C).
complex 2c (0.89 g, 1.81 mmol) was reacted with acetone (0.21 g, 0.27
NMR (300 MHz, C D ): δ −118.1. LR-MS (EI, m/z, relative intensity
mL, 3.62 mmol) in toluene (70 mL) for 2 h to give complex 3d as a white
6
6
+
+
+
1
(
%)): 486 ([M ], 13), 421 ([M − Cp], 2), 220 ([M − Fv], 100). Anal.
solid in 75% yield (0.83 g, 1.40 mmol). H NMR (500 MHz, C
D
6
6
): δ
Calcd for C3 H F Zr: C, 70.88; H, 4.91. Found: C, 70.72; H, 5.14.
7.04−7.52 (m, 8H, p-tol), 6.77 (m, 1H, H4), 6.31 (m, 1H, H3), 6.20 (s,
5H, Cp), 6.00 (s, 5H, Cp), 5.70 (s, 1H, H1), 2.84 (s, 1H, H ), 2.18 (s,
3H, CH ), 2.14 (s, 3H, CH ), 1.66 (s, 3H, CH ), 1.47 (s, 3H, CH ), 1.22
(s, 3H, CH ), 1.19 (s, 3H, CH ). C NMR (125 MHz, C ): δ 151.6
1.5
26 2
Crystals of complex 2e suitable for X-ray studies were grown from a
toluene solution at 4 °C. The compound crystallizes with 0.5 equiv of
toluene.
2
3
3
3
3
13
D
6 6
3
3
General Procedure (GP-3) for Reaction of Cp ZrFv Complex
(C), 144.9 (C), 142.6 (C), 137.8 (CH), 136.8 (CH), 135.7 (C), 135.4
(C), 133.5 (CH), 131.7 (CH), 128.8 (CH), 127.1 (CH), 111.7 (CH),
2
2
c with Carbonyl Compounds (Bulk Reaction). To a solution of
111.4 (CH), 87.3 (C), 80.9 (C), 64.8 (C), 62.7 (CH), 32.2 (CH ), 31.7
3
(CH ), 31.4 (CH ), 30.9 (CH ), 21.0 (CH ), 20.9 (CH ). LR-MS (EI,
3
3
3
3
3
+
+
m/z, relative intensity (%)): 594 ([M ], 1), 536 ([M − acetone], 4),
+
+
478 ([M − 2 acetone], 25), 413 ([M − 2 acetone − Cp], 35), 278
+
+
+
3
([M − acetone − Fv], 87), 220 ([Cp Zr ], 67), 91 ([C H -CH ],
2
6
4
100). No correct elemental analysis of the bulk product was obtained,
despite several attempts. Crystals suitable for X-ray studies were grown
from a hexane/toluene solution at −15 °C.
Cp Zr[OCEt C(p-tolyl) C H CEt O] (3e). According to GP-3,
2
2
2
5
3
2
C D ): δ 6.85−7.84 (m, 18H, p-tolyl and phenyl), 6.81 (d, J = 5.3 Hz,
complex 2c (0.47 g, 0.98 mmol) was reacted with 3-pentanone (0.17
g, 0.21 mL, 1.96 mmol) in toluene (60 mL) for 12 h to give complex 3e
as a white solid in 67% yield (0.43 g, 0.66 mmol). H NMR (500 MHz,
6
6
1
1
3
1
1
H, H4), 6.27 (m, 1H, H3), 6.06 (s, 5H, Cp), 5.97 (s, 5H, Cp), 5.94 (m,
1
H, H1), 5.50, (s, 1H, H21), 5.37 (s, 1H, H28), 3.52 (s, 1H, H ), 2.19 (s,
2
13
H, CH ), 2.08 (s, 3H, CH ). C NMR (125 MHz, C D ): δ 152.9 (C),
C D ): δ 6.94−7.81 (m, 8H, p-tol), 7.09 (m, 1H, H4), 6.31 (m, 1H, H3),
3
3
6
6
6
6
47.7 (C), 144.9 (C), 142.8 (C), 140.8 (C), 136.7 (CH), 136.1 (CH),
35.9 (C), 135.5 (C), 133.8 (CH), 132.2 (CH), 131.9 (CH), 130.3
6.26 (s, 5H, Cp), 6.05 (s, 5H, Cp), 5.34 (s, 1H, H1), 2.92 (s, 1H, H ),
2
2.32 (m, 1H, CH2CH3, 2.66 (m, 1H, CH CH ), 2.17 (s, 3H, CH ), 2.12
2
3
3
(
CH), 128.5 (CH), 128.3 (CH), 127.9 (CH), 127.7 (CH), 127.2 (CH),
(s, 3H, CH ), 2.03 (m, 1H, CH CH ), 1.83 (m, 1H, CH CH ), 1.64 (m,
3 2 3 2 3
H
Organometallics XXXX, XXX, XXX−XXX